scholarly journals Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study

BMJ Open ◽  
2018 ◽  
Vol 8 (11) ◽  
pp. e022803 ◽  
Author(s):  
Olayinka O Shiyanbola ◽  
Elizabeth Unni ◽  
Yen-Ming Huang ◽  
Cameron Lanier
Keyword(s):  
Type 2 Diabetes ◽  
Medication Adherence ◽  
Self Efficacy ◽  
Illness Perceptions ◽  
Illness Perception ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
High Concern

ObjectivesTo cluster the adherence behaviours of patients with type 2 diabetes based on their beliefs in medicines and illness perceptions and examine the psychosocial, clinical and sociodemographic characteristics of patient clusters.DesignCross-sectional study.SettingA face-to-face survey was administered to patients at two family medicine clinics in the Midwest, USA.ParticipantsOne hundred and seventy-four ≥20-year-old, English-speaking adult patients with type 2 diabetes who were prescribed at least one oral diabetes medicine daily were recruited using convenience sampling.Primary and secondary outcome measuresBeliefs in medicines and illness perceptions were assessed using the Beliefs about Medicines Questionnaire and the Brief Illness Perception Questionnaire, respectively. Self-reported medication adherence was assessed using the Morisky Medication Adherence Scale. Psychosocial correlates of adherence, health literacy and self-efficacy were measured using the Newest Vital Sign and the Self-efficacy for Appropriate Medication Use, respectively. Two-step cluster analysis was used to classify patients.ResultsParticipants’ mean age was 58.74 (SD=12.84). The majority were women (57.5%). Four clusters were formed (non-adherent clusters: ambivalent and sceptical; adherent clusters: indifferent and accepting). The ambivalent cluster (n=30, 17.2%) included low-adherent patients with high necessity beliefs, high concern beliefs and high illness perceptions. The sceptical cluster (n=53, 30.5%) included low adherent patients with low necessity beliefs but high concern beliefs and high illness perceptions. Both the accepting (n=40, 23.0%) and indifferent (n=51, 29.3%) clusters were composed of patients with high adherence. Significant differences between the ambivalent, sceptical, accepting and indifferent adherent clusters were based on self-efficacy, illness perception domains (treatment control and coherence) and haemoglobin A1c (p<0.01).ConclusionsPatients with diabetes in specific non-adherent and adherent clusters still have distinct beliefs as well as psychosocial characteristics that may help providers target tailored medication adherence interventions.

Correlation Between Functional Health Literacy and Self-efficacy in People with Type 2 Diabetes Mellitus: Cross-sectional Study

2021 ◽  
pp. 105477382110068
Author(s):  
Luis Angel Cendejas Medina ◽  
Renan Alves Silva ◽  
Magda Milleyde de Sousa Lima ◽  
Lívia Moreira Barros ◽  
Rafael Oliveira Pitta Lopes ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Self Efficacy ◽  
Cross Sectional Study ◽  
Functional Health ◽  
Bivariate Analysis ◽  
Sectional Study ◽  
Cross Sectional

To analyze the correlation between functional health literacy (FHL) and self-efficacy (SE) in people with type 2 Diabetes Mellitus. Cross-sectional study was conducted among September and October 2019, with 196 people with type 2 diabetes. Data were collected using the Functional Literacy in Health instrument (B-TOFHLA) and the Diabetes Management Self-Efficacy Scale for Patients with Type 2 Diabetes Mellitus (DMSES). Bivariate analysis was used to verify the relationship among the constructs. Most diabetics showed an average B-TOFHLA score of 74.75, considered adequate, and self-efficacy of 4.07, high. The association between SE and FHL in the bivariate analysis found no statistical significance ( p > .05), in the same sense as the B-TOFHLA score and the DMSES domains ( p > .05). Constructs were not related to each other in terms of skills arising from judgments and decisions with motivational confidence by the investigated audience.

scholarly journals A cross-sectional study to evaluate the validity of a novel patient-reported outcome measure of medication adherence in Type 2 Diabetes

2021 ◽  
Vol 29 (Supplement_1) ◽  
pp. i30-i30
Author(s):  
J Wells ◽  
A El-Husseini ◽  
A Jaffar ◽  
K Dolgin ◽  
G Hubert ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Medication Adherence ◽  
Medication Possession Ratio ◽  
Cross Sectional Study ◽  
Patient Reported Outcome ◽  
World Health ◽  
Sectional Study ◽  
Cross Sectional ◽  
Patient Reported

Abstract Introduction The average medication adherence (MA) among patients in developed countries living with a chronic disease is estimated to be roughly 50%.(1) Non-adherence is multi-factorial, owing to socio-economic and clinical factors, as well as arguably the most important factor, patients’ health beliefs and experiences. Patient Reported Outcome Measures (PROMs) are often uni-dimensional in their assessment of drivers of MA. This study has evaluated a novel PROM as part of a wider international research initiative focused on Type 2 Diabetes (T2D) which assesses four key factors of MA referred to as Social (S), Psychological (P), Usage (U) and Rationale (R), in short SPUR®. Aim To compare the validity of SPUR® against previously validated PROMs in patients with T2D. Methods This South London cross-sectional study surveyed adult participants with a confirmed diagnosis of T2D prescribed a minimum of one anti-hyperglycaemic medicine. Surveys were administered face-to-face by community pharmacists using a convenience sampling method based on interactions with pharmacy patients. The survey consisted of questions relating to socio-demographic and clinical data, the SPUR® tool and three previously validated PROMs (BeMQ-General®, MARS-10® and BeMQ-Specific®) as comparators to evaluate factors P, U and R respectively. The Medication Possession Ratio (MPR), a measure of a patient’s pill count in a given time period, was used as an objective comparator of adherence. Pearson’s correlation coefficients (r) were calculated to determine the strength of association between the validated PROMs and SPUR®, with T tests used as a measure of significance (p=&lt;0.05) as an evaluation of validity for SPUR®. Results The survey response rate was 21.6% (n=149/690). The modal age range for participants was 60–69 years of age (40.1%, n=60). Participants were predominantly educated to degree level (29.5%, n=44), White (48.3%, n=72) and retired (28.9%, n=43). Overall, 47.6% (n=71) of participants identified as female. Body Mass Index (BMI) data were available for 88.6% (n=132) of the sample with 42.4% (n=56/132) reporting a BMI &gt;30. In ascending order, moderate to strong positive correlations were observed between SPUR® and the comparative PROMs for factors P (r=0.464, p=&lt;0.0001), U (r=0.595, p=&lt;0.0001) and R (r=0.719, p=&lt;0.0001), indicating SPUR® to be a reliable measure of those MA factors. When assessing MA objectively, SPUR® demonstrated the strongest correlation (r=0.281, p=&lt;0.0001) to MPR compared with the validated tools, with MARS-10® as the closest comparator (r=0.266, p=0.001). Despite this, SPUR® did not overestimate MA, 83.8% (n=125) of the sample was identified as adherent based on MPR compared to 53% (n=79) with SPUR®. The latter more closely reflecting HbA1c data which identified 55.4% (n=31/56) as adherent. Conclusion Study strengths include the implementation of validated PROMs and two objective MA measures; however, the study sample size was limited. SPUR® has demonstrated its validity against validated PROMs whilst predicting adherence levels without exaggeration, which is often attributed to crude objective measures such as MPR.(2) SPUR® may therefore holistically identify the multiple factors linked to non-adherence, thus supporting the design of individualised interventions.. Such interventions are deemed by the World Health Organisation as potentially more impactful than developing new treatments.(1) References 1. Eduardo Sabaté (WHO/NMH/CCH). Adherence to long-term therapies: policy for action. World Heal Organ. Published online 2001. 2. Long JA, Wang A, Medvedeva EL, et al. Glucose control and medication adherence among veterans with diabetes and serious mental illness: Does collocation of primary care and mental health care matter? Diabetes Care. Published online 2014. doi:10.2337/dc13-0051

scholarly journals The Association between Diabetes-Related Distress and Medication Adherence in Adult Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Irene A. Kretchy ◽  
Augustina Koduah ◽  
Thelma Ohene-Agyei ◽  
Vincent Boima ◽  
Bernard Appiah
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
Diabetes Management ◽  
Cross Sectional Study ◽  
Diabetes Distress ◽  
Sectional Study ◽  
Cross Sectional

Background. Type 2 diabetes mellitus (T2DM) is a major public health problem associated with distress. T2DM can affect health outcomes and adherence to medications. Little is however known about the association between diabetes distress and medication adherence among patients with T2DM in Ghana. Objective. The objective of the present study is twofold: to estimate distress associated with T2DM and to examine its association with medication adherence. Methods. A hospital-based cross-sectional study was conducted among 188 patients with T2DM recruited from a diabetes specialist outpatient clinic at the Pantang Hospital in Accra, Ghana. Data were obtained using the Problem Areas In Diabetes (PAID) scale and the Medication Adherence Report Scale. Results. The findings showed that about 44.7% of the patients showed high levels of diabetes-related distress. Poor adherence to medications was recorded in 66.5% of the patients. Patients who were highly distressed had 68% lower odds of adhering to their medications compared to those who were not (OR: 0.32, 95% CI: 0.15-0.65). A principal component analysis revealed four areas of T2DM distress which were conceptualized as negative emotions about diabetes, dietary concerns and diabetes care, dissatisfaction with external support, and diabetes management helplessness. Conclusion. Our findings suggest that diabetes distress is a significant determinant of medication adherence behaviour in patients with T2DM. Thus, incorporating routine screening for distress into the standard diabetes care within the Ghanaian health system and having health practitioners adopt holistic approaches to diabetes management will be important context-specific interventions to improve adherence and health outcomes of people living and coping with T2DM.

scholarly journals Medication Adherence among Type 2 Diabetes Mellitus Patients: A Cross Sectional Study in Rural Karnataka (India)

2021 ◽  
Vol 8 (2) ◽  
pp. 107-118
Author(s):  
Hemant Kumar ◽  
Rufaidha Amara Abdulla ◽  
Heena Lalwani
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
Cross Sectional Study ◽  
Research Centre ◽  
Sectional Study ◽  
Cross Sectional ◽  
Validated Questionnaire

India currently represents 17% of the world’s diabetes burden, with an estimated 77 million cases in 2019, a figure expected to almost double to 134 million by 2025. Currently, one in every four persons under 25 has adult-onset diabetes, a condition more usually seen in 40–50 year old people. A hospital-based cross-sectional study conducted among diabetes type 2 patients in a rural field practice area of the A.J. Institute of Medical Sciences & Research Centre, Mangalore, Karnataka. Medication adherence and factors associated with non-adherence to medication were determined using self-structured validated questionnaire. A total of 206 patients with type 2 diabetes were recruited. In the present study 49% of the patients were found to be having poor medication adherence, while 50.9% were found to be with good adherence. However, none of the patients showed perfect adherence. A significant association was observed between medication adherence and age of patients, their gender, information about the disease, family support, personal motivation, literacy status and cost of treatment. Keywords: medication adherence, type 2 diabetes mellitus, self-care practices, prevalence

scholarly journals Medication adherence in type 2 diabetes mellitus patients during Covid-19 pandemic: a cross-sectional study from the United Arab Emirates

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 435
Author(s):  
Ameena Asheq ◽  
Akram Ashames ◽  
Moawia Al-Tabakha ◽  
Nageeb Hassan ◽  
Ammar Jairoun
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
United Arab Emirates ◽  
Cross Sectional Study ◽  
Diabetic Patients ◽  
Sectional Study ◽  
Cross Sectional

Background: Patients with chronic diseases often experience difficulty adhering to recommended treatments as instructed by their healthcare professionals. Recently, diabetes has been associated with the severity of the novel coronavirus disease (Covid-19), which raises the importance of improving medication adherence for diabetic patients to enhance the right use of antidiabetics amid the Covid-19 pandemic. Methods: This work assesses medication adherence among type 2 diabetes mellitus patients in the United Arab Emirates (UAE) and identifies the set of key demographic and health factors significantly associated with medication adherence. A descriptive cross-sectional study was conducted on an appropriate sample of type 2 diabetic patients in the UAE, with 180 patients of both genders and various social levels. A validated version of the eight-item Morisky Medication Adherence Scale (MMAS) was used for data collection. Results:  The average MMAS score was 4.88, with 95% confidence intervals (CI) 4.6 and 5.2. 61.67% (n=111), 28.89% (n=52), and 9.44% (n=17) of patients were categorized into low, medium, and high adherent groups, respectively. These findings indicate that a high level of non-compliance to antidiabetic regimens among the population in the UAE. Conclusions: Patients demonstrated low level of compliance to antidiabetic regimens. Therefore, they must receive up-to-date knowledge about the disease and the treatment and enable easy access to their health care providers to enhance medication adherence.

scholarly journals Medication adherence in type 2 diabetes mellitus patients during Covid-19 pandemic: a cross-sectional study from the United Arab Emirates

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 435
Author(s):  
Ameena Asheq ◽  
Akram Ashames ◽  
Moawia Al-Tabakha ◽  
Nageeb Hassan ◽  
Ammar Jairoun
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
United Arab Emirates ◽  
Cross Sectional Study ◽  
Diabetic Patients ◽  
Sectional Study ◽  
Cross Sectional

Background: Patients with chronic diseases often experience difficulty adhering to recommended treatments as instructed by their healthcare professionals. Recently, diabetes has been associated with the severity of the novel coronavirus disease (Covid-19), which raises the importance of improving medication adherence for diabetic patients to enhance the right use of antidiabetics amid the Covid-19 pandemic. Methods: This work assesses medication adherence among type 2 diabetes mellitus patients in the United Arab Emirates (UAE) and identifies the set of key demographic and health factors significantly associated with medication adherence. A descriptive cross-sectional study was conducted on an appropriate sample of type 2 diabetic patients in the UAE, with 180 patients of both genders and various social levels. A validated version of the eight-item Morisky Medication Adherence Scale (MMAS) was used for data collection. Results:  The average MMAS score was 4.88, with 95% confidence intervals (CI) 4.6 and 5.2. 61.67% (n=111), 28.89% (n=52), and 9.44% (n=17) of patients were categorized into low, medium, and high adherent groups, respectively. These findings indicate that a high level of non-compliance to antidiabetic regimens among the population in the UAE. Conclusions: Patients demonstrated low level of compliance to antidiabetic regimens. Therefore, they must receive up-to-date knowledge about the disease and the treatment and enable easy access to their health care providers to enhance medication adherence.

Sign in / Sign up

Export Citation Format

Share Document